Mohamed Wa'el Ahmed Hashad's Net Worth
$538 Thousand
Who is Mohamed Wa'el Ahmed Hashad?
Mohamed Wa'el Ahmed Hashad does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Longeveron Inc., and Akari Therapeutics Plc.
SEC CIK
Mohamed Wa'el Ahmed Hashad's CIK is 0001966752
Past Insider Trading and Trends
2024 was Mohamed Wa'el Ahmed Hashad's most active year for acquiring shares with 6 total transactions. Mohamed Wa'el Ahmed Hashad's most active month to acquire stocks was the month of February. 2023 was Mohamed Wa'el Ahmed Hashad's most active year for disposing of shares, totalling 11 transactions. Mohamed Wa'el Ahmed Hashad's most active month to dispose stocks was the month of August. 2023 saw Mohamed Wa'el Ahmed Hashad paying a total of $30,000.00 for 110,000 shares, this is the most they've acquired in one year. In 2024 Mohamed Wa'el Ahmed Hashad cashed out on 77,237 shares for a total of $121,060.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Longeveron Inc. (LGVN) Snapshot price: $1.96
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +182.27% | 272K |
$2.46 | -$96,550.08 | 421.23K |
Aug 15
| |||
Form 4
| +118.49% | 10.64K |
$2.35 | $24,999.30 | 19.62K |
Apr 11
| |||
Form 4
| +111.52% | 47.33K |
$0.54 | -$17,747.64 | 89.78K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -10.77% | -5.12K |
$1.32 | -$6,762.36 | 42.44K |
Jan 2
| |||
Form 4
| +26.62% | 10K |
$3.00 | $30,000.00 | 47.57K |
Sep 12
| |||
Form 4
| -10.32% | -4.32K |
$2.64 | -$11,412.72 | 37.57K |
Sep 1
| |||
Form 4
| -9.29% | -4.29K |
$3.25 | -$13,949.00 | 41.89K |
Aug 18
| |||
Form 4
| -7.64% | -3.82K |
$2.61 | -$9,967.59 | 46.18K |
Apr 5
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akari Therapeutics Plc (AKTX) Snapshot price: $3.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||